APLS - SHAREHOLDER ALERT: Levi & Korsinsky Notifies Apellis Pharmaceuticals Inc. (APLS) Investors of a Class Action Lawsuit and Upcoming Deadline | Benzinga

NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Apellis Pharmaceuticals, Inc. ("Apellis" or the "Company") (NASDAQ:APLS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Apellis investors who were adversely affected by alleged securities fraud between January 28, 2021 and July 28, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/apellis-lawsuit-submission-form?prid=44803&wire=3

APLS investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made ...

APLS) Investors of a Class Action Lawsuit and Upcoming Deadline>Full story available on Benzinga.com